FUNDAMENTAL ASPECTS AND PRACTICAL PRINCIPLES OF LECTIN SYSTEMS ON THE EXAMPLE OF SYMBIOTIC MICROBIOCENOSIS STRAINS AND CONSORTIA

Prospects of lectin systems of the human biotope symbiotic microorganisms are evaluated. Symbiotic lectins are described as metabolome-biotic imitators of probiotics, carriers, deliveries, depositors, and agents realizing glycoconju-gate metabiotics. Glycoconjugate metabiotics (adequate to symbiotic lectins) represent antagonistic factors against relatively pathogenic microorganisms. Such glycoconjugates include prebiotics, therapeutic agents, décor panels currently supporting normally functioning human cells, tissues and organs. Symbiotic lectins, interacting to synthetic glycoconjugate imitators of important substances for human interactome, serve as instruments for screening strains and their consortia possessing new potential for constructing multistrain pro- and symbiotics. Algorithms of such screening and constructing based on lectins-glycoconjugates interactions are developed. Proposed anaerobic (without oxidoreductase systems participating in oxidative stress) relatively high molecular mass synergistic symbiotic lectins (in contrast to low molecular mass acidic symbiotic effectors) are perspective as network multifunctional switching assistive recognition systems functioning in agreement to human protective systems (complement, lymphocytes, macrophages) in the absence of local availability of oxygen. Results support new technological prospects of the direct and indirect resulting protection involving human intestinal indigenous symbiotic (probiotic) lectin systems against surrounding pathogenic and/or relatively pathogenic exo- and endogenic microorganisms in biotopes of organism.

glycoconjugates, lectin systems, probiotics, symbiotics, consortia, protection of organism, bifidobacteria, lactobacilli, yeast-like fungi, Gram-positive bacteria

1. Лахтин М.В., Байракова А.Л., Лахтин В.М., Афанасьев С.С., Алешкин В.А. Лектины пробиотиков -новый класс сигнальных молекул чувства кворума // Клиническая лабораторная диагностика. - 2012. -Т. 57, № 9. - С. 82-83

2. Лахтин М.В., Лахтин В.М., Алешкин В.А., Афанасьев С.С., Алешкин А.В. Лектины и ферменты в биологии и медицине. - М.: Издательство «Династия», 2010. - 496 с

3. Лахтин М.В., Лахтин В.М., Алешкин В.А., Афанасьев С.С., Пожалостина Л.В., Поспелова В.В., Корсун В.Ф. Фито-и пробиотические лектины - синергичные антипатогены // Практическая фитотерапия. -2010. - № 1. - C. 5-11

4. Лахтин М.В., Лахтин В.М., Афанасьев С.С., Алешкин В.А. Взаимоотношения систем комплемента, Toll-подобных рецепторов, CD-антигенов и цитокинов в норме и при патологиях. Обзор // Бюл. ВСНЦ СО РАМН. - 2015. - № 6. - С. 62-66

5. Лахтин М.В., Лахтин В.М., Афанасьев С.С., Алешкин В.А. Мукозальный иммунитет против патогенов и опухолей с участием системы «Лектины пробиотиков - гликополимеры» // Бюл. ВСНЦ СО РАМН. -2015. - № 3. - С. 63-71

6. Лахтин М.В., Лахтин В.М., Афанасьев С.С., Байракова А.Л., Караулов А.В., Афанасьев М.С., Алешкин В.А. Мобильный синбиотопный микробиоценоз против патогенов // Бюл. ВСНЦ СО РАМН. - 2016. - № 3-2. -С. 168-173

7. Lakhtin M., Aleshkin V., Lakhtin V., Afanasiev S., Pozhalostina L., Pospelova V. (2010). Probiotic lactobacillus and bifidobacterial lectins against Candida albicans and Staphylococcus aureus clinical strains: new class of pathogen biofilm destructors. Probiotics Antimicrob. Proteins, 2 (3), 186-196. doi: 10.1007/s12602-010-9046-3.

8. Lakhtin M.V., Lakhtin V.M., Afanasiev S.S., Aleshkin V.A. (2016). Mucosal opened cavities as the organ of increased resistance and effectiveness. J. Adv. Biol. Biotech., 10 (3), 1-10. Doi: http://dx.doi.org/10.9734/jabb.

9. Lakhtin M., Lakhtin V., Afanasiev S., Bajrakova A., Aleshkin V., Afanasiev M.S., Karaulov A.V., Korsun V. (2014). Human healthy status supported by probiotic systems recognizing glycoconjugates: one more strategy of supporting healthy biotope. European Science and Technology: Materials of the IX International Research and Practice Conference (Munich, Dec. 24-25th), 414-422.

10. Lakhtin M., Lakhtin V., Aleshkin V., Afanasiev S. (2011). Lectins of beneficial microbes: system organization, functioning and functional superfamily. Beneficial Microbes, 2 (2), 155-165. doi: http://dx.doi.org/10.3920/ BM2010.0014.

11. Lakhtin M., Lakhtin V., Aleshkin A., Bajrakova A., Afanasiev S., Aleshkin V. (2012). Lectin systems imitating probiotics: potential for biotechnology and medical microbiology. Probiotics. New York, 417-432.

12. Lakhtin V.M., Lakhtin M.V., Bajrakova A.L., Afanasiev S.S. (2013). Candida albicans: new aspects of patogenicity, interaction to antifungals, biofilms and preventive anti-Candida strategies - the overview of own works. Candida Albicans: Symptoms, Causes and Treatment Options. New York, 145-152.